7invensun, a Zhongguancun, China-based eye-tracking technology company, received an equity investment from Qualcomm.
The amount of the deal was not disclosed.
Founded in 2009 by CEO Huang Tongbing, 7invensun is committed to developing eye-tracking and movement control technology. Its Almighty Eye series of eye-control and head-control devices for augmentative and alternative communication (AAC) have been used by over 10,000 patients amyotrophic lateral sclerosis (ALS) patients and high paraplegia patients to recover communication ability through an eye-tracking typing method.
The company is now seeking partners worldwide interested in eye-tracking technology to co-develop an eye-tracking technology ecosystem.
FinSMEs
12/09/2016